Document Detail

Cost-effectiveness of pharmacologic and invasive therapies for stroke prophylaxis in atrial fibrillation.
MedLine Citation:
PMID:  22193838     Owner:  NLM     Status:  Publisher    
Atrial fibrillation is an abnormal heart rhythm characterized by rapid, disorganized activation (fibrillation) of the left and right atria of the heart, and is responsible for 15% of 700 000 strokes in the United States each year. There are multiple pharmacologic and nonpharmacologic therapies used for stroke prevention in atrial fibrillation, including vitamin K antagonists such as warfarin, antiplatelet agents such as aspirin and clopidogrel, and newer agents such as dabigatran, rivaroxaban and apixaban. Nonpharmacologic therapies involve excluding the left atrial appendage from the systemic circulation by surgical ligation or excision, percutaneous ligation, or endovascular implantation of a left atrial occlusion device. Because atrial fibrillation-related stroke is preventable, a comparison of the value of these interventions by cost-effectiveness analysis (CEA) could inform clinical and health policy recommendations. In this article, we review the principles of CEA and identify 11 articles that examine CEA of stroke prophylaxis strategies in atrial fibrillation. Although most studies evaluate aspirin and warfarin across a variety of atrial fibrillation stroke risk profiles, we also review new literature on new pharmacologic therapies such as direct thrombin inhibitors and discuss the potential value of device-based therapies.
Matthew D Solomon; Aditya J Ullal; Donald D Hoang; James V Freeman; Paul Heidenreich; Mintu P Turakhia
Related Documents :
22647518 - A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selecti...
22273728 - Perflurooctanoic acid induces developmental cardiotoxicity in chicken embryos and hatch...
21700928 - Reversibility of adverse, calcineurin-dependent cardiac remodeling.
21805588 - Correlation between index electrocardiographic patterns and pre-intervention angiograph...
19531728 - Randomized control trial investigating the influence of coffee on heart rate variabilit...
8551198 - Continuous vectorcardiographic changes in relation to scintigraphic signs of reperfusio...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-21
Journal Detail:
Title:  Journal of cardiovascular medicine (Hagerstown, Md.)     Volume:  -     ISSN:  1558-2035     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101259752     Medline TA:  J Cardiovasc Med (Hagerstown)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
aVeterans Affairs Palo Alto Healthcare System, Palo Alto bDepartment of Medicine (Cardiovascular Medicine), Stanford University, Stanford, California, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Catheter ablation of atrial fibrillation: state-of-the-art techniques and future perspectives.
Next Document:  Medical treatment of atrial fibrillation.